Clinical Trial Update: A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and clinical activity of belantamab mafodotin in adults with primary immune thrombocytopenia who have previously …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Belantamab Mafodotin (belantamab mafodotin)

Snippet

Sponsor: Hellenic Society of Hematology | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 2 | Status: NOT_YET_RECRUITING